Sucampo Pharma (SCMP) Misses Q1 EPS by 17c, Reiterates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Sucampo Reports First Quarter 2017 Financial Results
May 3, 2017 6:30 AM EDTContinued Revenue Growth
Recent Vtesse Acquisition Bolsters Pipeline
Company Reiterates 2017 Guidance
Company to Host Conference Call Today at 8:30 a.m. EDT
ROCKVILLE, Md., May 03, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the first quarter ended March 31, 2017.
... More